Systemic Risks of Mandatory Testosterone Screening in the U.S. Military: Overdiagnosis, Gender Bias, and Institutional Incentives
Original framing: “Opinion: Beware the unintended consequences of testosterone screening for military servicemembers” — STAT News
Current evidence indicates that routine testosterone screening in asymptomatic adults yields low predictive value for performance outcomes and may lead to overprescription of anabolic agents. Randomized trials in civilian populations have not demonstrated clear benefits for strength or endurance, and the risk of adverse cardiovascular events remains uncertain. A scientifically rigorous policy would therefore require strict indication criteria and longitudinal outcome monitoring.
The push for universal testosterone screening in the U.S. military is less a neutral health measure than a convergence of institutional performance pressures, pharmaceutical incentives, and entrenched gender norms.
Historical precedents of medical surveillance reveal how such policies can become tools of bodily discipline, while cross‑cultural and indigenous perspectives remind us that strength is cultivated through community, balance, and ritual, not merely hormone levels. By foregrounding marginalized service members' lived experiences and integrating holistic wellness frameworks, the military can shift from a reductionist biomedical model to a resilient, equitable system. Independent oversight and rigorous longitudinal research will provide the evidence base needed to recalibrate the policy, ensuring that future readiness is built on sustainable health rather than biochemical augmentation.